Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$2.35 - $4.47 $27,025 - $51,405
-11,500 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$3.5 - $5.16 $7,700 - $11,352
-2,200 Reduced 16.06%
11,500 $0
Q4 2021

Feb 14, 2022

BUY
$4.83 - $7.56 $66,171 - $103,572
13,700 New
13,700 $3,000
Q3 2021

Nov 10, 2021

SELL
$6.2 - $8.34 $98,580 - $132,606
-15,900 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$6.04 - $8.37 $96,036 - $133,083
15,900 New
15,900 $21,000

Others Institutions Holding ACIU

About AC Immune SA


  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $233M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.